Filistor Destempasidis

Political turmoil and reactions have erupted after “Proto Thema” revealed that protected witnesses in the Novartis case shared €56 million. Given the witnesses’ personal gain, as disclosed by the article, it is now necessary to lift their protected status and remove their anonymity. The critical question remains: who prompted them to make the allegations that fueled the Novartis conspiracy?

Within hours of the owner of an advertising agency telling a Greek corruption prosecutor that he paid an unnamed representative of the Swiss pharmaceutical company Novartis some 400,000 euros, the executive, Filistor Destempasidis, issued a statement rejecting the claims as "monstrous degeneracy" and pledged to take legal action.